← Back to Search

Behavioral Intervention

Family-Centered Care for Domestic Violence

N/A
Recruiting
Led By Gunjan Tiyyagura, MD, MHS
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have a child < 3-years-old who been reported to Child Protectives Services for IPV exposure
Able to speak English or Spanish fluently
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year post visit 1, until child is 2 years of age
Awards & highlights

Study Summary

This trial looks at how different approaches to care for families affected by IPV can affect caregivers, children, and outcomes.

Who is the study for?
This trial is for parents over 18 with a child under 3 who's been exposed to domestic violence and reported to Child Protective Services. Participants must speak English or Spanish, agree to a medical evaluation for the child, and not already be connected to an IPV advocate or be a ward of the state.Check my eligibility
What is being tested?
The study compares Family-Centered Care (FCC) with Child-centered care (CCC) in terms of how they affect caregiver engagement in community services, feelings of empowerment, and clinical outcomes for children who have witnessed domestic violence.See study design
What are the potential side effects?
Since this trial involves care models rather than medications, traditional side effects are not applicable. However, participants may experience emotional discomfort or stress due to discussions about intimate partner violence.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child under 3 has been reported to CPS due to exposure to IPV.
Select...
I am fluent in English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year post visit 1, until child is 2 years of age
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year post visit 1, until child is 2 years of age for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of caregivers with follow-up visits with an IPV advocate
Secondary outcome measures
Frequency of IPV-related episodes assessed using the Conflict Tactic Scale 2 (CTS2) for partner's behaviors
Frequency of IPV-related episodes assessed using the Psychological Maltreatment of Women Inventory (PMWI)- Short form
Immunization status determined by the number of participants that received all recommended vaccinations
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: FCC modelExperimental Treatment1 Intervention
Participants will receive family-focused care.
Group II: CCC modelActive Control1 Intervention
Participants will receive the usual child-focused care.

Find a Location

Who is running the clinical trial?

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
1,965 Previous Clinical Trials
2,672,462 Total Patients Enrolled
Yale UniversityLead Sponsor
1,852 Previous Clinical Trials
2,738,106 Total Patients Enrolled
Gunjan Tiyyagura, MD, MHSPrincipal InvestigatorYale University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can any new participants still enroll in this medical experiment?

"As evidenced by the details on clinicaltrials.gov, this medical trial is no longer actively seeking candidates; it was initially posted on November 1st 2023 and had its last update on September 29th 2023. Nevertheless, there are currently 13 other trials welcoming participants."

Answered by AI
~223 spots leftby Feb 2027